2Ramaswamy S, Ross K N, Lander E S, et al. A molecular signature of metastasis in primary solid tumors [J]. Nat Genet, 2003,33 ( 1 ) : 49-54.
3Zou H, McGarry T J, Bernal T, et al. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis [J]. Science, 1999,285 (5426) :418-422.
4Hamid T, Kakar S S. PTTG/securin activates expression of p53 and modulates its function [J]. Mol Cancer, 2004,3:18.
5Heaney A P, Singson R, McCabe C J, et al. Expression of pituitary-tumour transforming gene in colorectal tumours [J]. Lancet, 2000,355 (9205) : 716-719.
6Klein D. Quantification using real-time PCR technology: applications and limitations [J]. Trends Mol Med, 2002,8 (6) : 257-260.
7Kanellos I, Zacharakis E, Kanellos D, et al. Prognostic significance of CEA levels and detection of CEA mRNA in draining venous blood in patients with colorectal cancer [J]. J Surg Oncol, 2006,94( 1 ) : 3-8.
8Liska V, Holubec L Jr, Treska V, et al. Dynamics of serum levels of tumour markers and prognosis of recurrence and survival after liver surgery for colorectal liver metastases [J ]. Anticancer Res, 2007,27 (4C) : 2861-2864.
9Uehara M, Manaka D, Baba S, et al. prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer [J]. Gan To Kagaku Ryoho, 2007,34(9) : 1413-1417.
10Irvine T, Scott M, Clark C I. A small rise in CEA is sensitive for recurrence after surgery for colorectal cancer [J]. Colorectal Dis, 2007,9 (6) : 527-531.
